NCT02750748View on ClinicalTrials.gov

Pharmacokinetic Evaluation of Intranasal, Intramuscular, and Oral Naltrexone in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Opioid-Related Disorders
Interventions
DRUG

Naltrexone

OTHER

Intravail

Trial Locations (1)

66212

Vince and Associates Clinical Research, Inc., Overland Park

All Listed Sponsors
lead

National Institute on Drug Abuse (NIDA)

NIH

NCT02750748 - Pharmacokinetic Evaluation of Intranasal, Intramuscular, and Oral Naltrexone in Healthy Volunteers | Biotech Hunter | Biotech Hunter